Chronic Pruritus: Current and Emerging Treatment Options.

Area of Science:

• Dermatology
• Neurology
• Psychiatry

Background:

• Chronic pruritus is a widespread condition with significant negative effects on patient quality of life.
• It can stem from various conditions, including dermatological, systemic, neurological, and psychiatric diseases, often with unknown or multiple causes.
• The heterogeneous nature of chronic pruritus presents therapeutic challenges for clinicians.

Purpose of the Study:

• To review the current understanding and management of chronic pruritus.
• To highlight the complexity arising from its diverse etiologies and co-existing conditions.
• To discuss novel therapeutic strategies and ongoing research in antipruritic drug development.

Main Methods:

• Review of existing literature on chronic pruritus.
• Analysis of current and emerging treatment modalities, including topical and systemic agents.
• Examination of recent randomized controlled trials for novel antipruritic compounds.

Main Results:

• Standard treatments include basic measures (emollients, treating underlying disease) and topical/systemic agents (e.g., calcineurin inhibitors, corticosteroids, immunosuppressants, gabapentinoids).
• Management also involves addressing associated disorders like sleep impairment, depression, and anxiety.
• Numerous novel antipruritic drugs targeting pathways like nerve growth factor, neuropeptides, histamine 4, interleukin receptors, and opioid receptors are under investigation.

Conclusions:

• Effective management of chronic pruritus requires a multifaceted approach, addressing the symptom, underlying causes, and associated comorbidities.
• Recent advancements in understanding pruritus pathways have spurred the development of targeted therapies.
• Ongoing clinical trials for novel biological compounds show promise for future treatment of chronic pruritus.